Group names for herbal medicines: the need for introduction and rationale for establishing

Group names for herbal medicines: the need for introduction and rationale for establishing

The article considers the importance of International Nonproprietary Names (INNs) and group names in the development of common information standards for the industry in the light of creation of the EurAsEC market and shared information space. The necessity to define the rules for assigning group nam...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	M. N. Lyakina, E. L. Kovaleva, O. B. Nikolaeva, N. M. Krutikova, N. G. Olenina, L. A. Kolganov
Format:	Artykuł
Język:	Russian
Wydane:	Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2018-02-01
Seria:	Регуляторные исследования и экспертиза лекарственных средств
Hasła przedmiotowe:	международное непатентованное наименование группировочное наименование лекарственные растительные средства рациональность international nonproprietary name generic name herbal medicines rationality
Dostęp online:	https://www.vedomostincesmp.ru/jour/article/view/84

Podobne zapisy

International nonproprietary names of drugs: requirements for an application and order of examination and registration of the world health organization
od: V. V. Dudchenko, i wsp.
Wydane: (2018-02-01)

International nonproprietary names for biological and biotechnological drugs
od: V. V. Dudchenko, i wsp.
Wydane: (2018-02-01)

Общие вопросы определения права на фирменное наименование. Фирмалық атауды анықтау мәселелерінің жалпы сұрақтары.
od: A. B. Omarova.
Wydane: (2016-02-01)

О СОДЕРЖАНИИ НЕКОТОРЫХ ОСНОВНЫХ ПОНЯТИЙ В СПЕЦИАЛЬНЫХ ЯЗЫКАХ (НА ОСНОВЕ ЯЗЫКА ПРАВА)
od: Мария Мущинина
Wydane: (2012-12-01)

РЕЦЕНЗІЯ НА ЗБІРНИК ПРАЦЬ: Бучко Г., Бучко Д. Історична та сучасна українська ономастика: Вибрані праці / Ганна Бучко, Дмитро Бучко. – Чернівці: «Букрек», 2013. – 456 с. / Review of the proceedings: Buchko G., D. Buchko. The Historical and Modern Ukrainian Onomastics: Selected Works / Anna Buchko, Dmitry Buchko. – Chernivtsi: "Bukrek", 2013. – 456 p.
od: Максимюк Марта
Wydane: (2015-03-01)

Domain Names and Trademarks: Law Enforcement Issues
od: N. A. Permyakova
Wydane: (2015-06-01)

"СХОДСТВО ДО СТЕПЕНИ СМЕШЕНИЯ": ЛИНГВИСТИЧЕСКИЙ АСПЕКТ
od: Svetlana Doronina
Wydane: (2016-12-01)

Rastitel'nye preparaty v lechenii zhelezodefitsitnykh anemiy (obzor literatury)
od: A V Ledina
Wydane: (2004-10-01)

Наименования женщин по брачному статусу: компонентный анализ (на материале тувинского и казахского языков)
od: Зифа Какбаевна Темиргазина, i wsp.
Wydane: (2023-12-01)

Challenges Associated with Forming Generic Names for Herbal Medicinal Products
od: L. N. Frolova, i wsp.
Wydane: (2024-04-01)

Метод сопоставления эффективности медикаментозного лечения артериальной гипертензии = The method of comparing the effectiveness of drug treatment of hypertension
od: L. Yu. Babintseva
Wydane: (2015-10-01)

CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE
od: S. V. Gatsura, i wsp.
Wydane: (2015-09-01)

International nonproprietary names for monoclonal antibodies: an evolving nomenclature system
od: Sofia S. Guimaraes Koch, i wsp.
Wydane: (2022-12-01)

CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE
od: S. V. Gatsura, i wsp.
Wydane: (2015-09-01)

Метод сопоставления эффективности медикаментозного лечения артериальной гипертензии = The method of comparing the effectiveness of drug treatment of hypertension
od: L. Yu. Babintseva
Wydane: (2015-10-01)

Phytopharmacology: at the origins of pharmacy and clinical pharmacology
od: D. A. Sychev, i wsp.
Wydane: (2014-04-01)

MARKETING REVIEW OF THE PHARMACEUTICAL MARKET ANTIHISTAMINE MEDICINES
od: I.A. Kostiuk, i wsp.
Wydane: (2016-09-01)

A Verdade do Sujeito e sua Veiculação pelos Nomes
od: Oswaldo França Neto
Wydane: (2018-11-01)

The regional system perfection of medical products providing and quality assurance in Zabaykalsky region as the example
od: Y A Rezvykh, i wsp.
Wydane: (2013-12-01)

Over-the-counter drugs and self-medication
od: L B Okonenko, i wsp.
Wydane: (2009-12-01)

Improvement of regional system of providing and quality control of medicines (on the example of zabaykalsky region)
od: Y A Rezvykh, i wsp.
Wydane: (2013-12-01)

Teplovision visualisation medicinal facilities and infiltrovannych by them fabrios at injections
od: А J Маlchikov, i wsp.
Wydane: (2009-12-01)

Pharmacological incompatibility
od: A. I. Vengerovsky
Wydane: (2003-09-01)

An alternative method of loss on drying determination in herbal medicinal products
od: N. P. Antonova, i wsp.
Wydane: (2018-02-01)

Annotated list of introduced species of herbaceous plants cultivated in Petrozavodsk
od: Antipina G S, i wsp.
Wydane: (2012-12-01)

Modern approaches to herbal preparations efficacy and safety assessment in Russia and abroad
od: E. I. Sakanyan, i wsp.
Wydane: (2018-02-01)

Substitutes of Prescription Medicines - A Review of Concerns Relevant to Doctors and Patients
od: Jayant Kumar Kairi, i wsp.
Wydane: (2017-08-01)

Is Brand Name Best? Brand name versus generic pharmaceuticals in clinical practice
od: Andrea Bakker
Wydane: (2017-06-01)

Actual aspects of standardization of medicinal vegetative raw materials containing flavonoids
od: A. V. Kurkina
Wydane: (2011-10-01)

Lekarstvennaya terapiya somaticheskikh zabolevaniy u beremennykh i rodil'nits
od: M M Shekhtman, i wsp.
Wydane: (2008-12-01)

Heart failure as a risk factor of adverse drug reactions. Part 2: potential changes in pharmacokinetics of some drugs
od: A. P. Pereverzev, i wsp.
Wydane: (2022-02-01)

The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
od: Karan eThakkar, i wsp.
Wydane: (2013-09-01)

Biosimilars - advantages and prospects
od: A. A. Lidzhiyeva, i wsp.
Wydane: (2018-02-01)

Specifics of herbal drugs quality testing with the examples of typical criticism of laboratory testing of those
od: N. P. Antonova, i wsp.
Wydane: (2018-02-01)

Clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia
od: Cheng-Yi Wang, i wsp.
Wydane: (2022-09-01)

Stress studies and photostability as a part of pharmaceutical drug development data
od: L. I. Mit'kina, i wsp.
Wydane: (2018-02-01)

State of the Russian pharmaceutical industry at the present stage
od: E. N. Hoseva
Wydane: (2018-06-01)

Psychiatrists’ prescriptions
od: Poduri Gopala Sarma
Wydane: (2015-01-01)

Quality control of herbal drugs and preparations: The methods of analysis, their relevance and applications
od: N.W. Muyumba, i wsp.
Wydane: (2021-12-01)

Opinions of Czech general practitioners on generic drugs and substitution
od: Dosedel Martin, i wsp.
Wydane: (2014-12-01)